The Phase 3 study found a drug didn’t reduce the risk of cardiovascular events like heart attacks and strokes.
Source link
Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal
Date:
More like thisRelated
Netanyahu's party lags in polls ahead of first election since Oct. 7, 2023
Benjamin Netanyahu's Likud party is lagging behind in the...
Smith-Njigba has banner day, Seahawks’ defense stifles Chiefs
Nate Taylor and Brady HendersonCloseBrady HendersonESPNBrady Henderson is a reporter for...
SS United States Soon to Become World’s Largest Artificial Reef
DESTIN, Fla. —A historic ocean liner is a step...